These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22309430)

  • 21. Paradoxical excitation on diphenhydramine may be associated with being a CYP2D6 ultrarapid metabolizer: three case reports.
    de Leon J; Nikoloff DM
    CNS Spectr; 2008 Feb; 13(2):133-5. PubMed ID: 18227744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial.
    Serrano D; Lazzeroni M; Zambon CF; Macis D; Maisonneuve P; Johansson H; Guerrieri-Gonzaga A; Plebani M; Basso D; Gjerde J; Mellgren G; Rotmensz N; Decensi A; Bonanni B
    Pharmacogenomics J; 2011 Apr; 11(2):100-7. PubMed ID: 20309015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
    Sumiyoshi T; Jayathilake K; Meltzer HY
    Schizophr Res; 2003 Jan; 59(1):7-16. PubMed ID: 12413636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melperone in treatment-refractory schizophrenia: a case series.
    Whiskey E; Vavrova M; Gaughran F; Taylor D
    Ther Adv Psychopharmacol; 2011 Feb; 1(1):19-23. PubMed ID: 23983923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone.
    Scordo MG; Spina E; Facciolà G; Avenoso A; Johansson I; Dahl ML
    Psychopharmacology (Berl); 1999 Dec; 147(3):300-5. PubMed ID: 10639689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome.
    Panagiotidis G; Arthur HW; Lindh JD; Dahl ML; Sjöqvist F
    Ther Drug Monit; 2007 Aug; 29(4):417-22. PubMed ID: 17667795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia.
    Sumiyoshi T; Jayathilake K; Meltzer HY
    Schizophr Res; 2003 Jul; 62(1-2):65-72. PubMed ID: 12765745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Dynamics Simulations Reveal Structural Differences among Allelic Variants of Membrane-Anchored Cytochrome P450 2D6.
    Fischer A; Don CG; Smieško M
    J Chem Inf Model; 2018 Sep; 58(9):1962-1975. PubMed ID: 30126275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.
    Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C
    Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does pharmacogenetic testing for CYP450 2D6 and 2C19 among patients with diagnoses within the schizophrenic spectrum reduce treatment costs?
    Herbild L; Andersen SE; Werge T; Rasmussen HB; Jürgens G
    Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):266-72. PubMed ID: 23731498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of the interindividual variability of cytochrome 2D6 activity from urinary metabolic ratios in the literature.
    Ito T; Kato M; Chiba K; Okazaki O; Sugiyama Y
    Drug Metab Pharmacokinet; 2010; 25(3):243-53. PubMed ID: 20610883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population.
    Salyakina D; Roy S; Wang W; Oliva M; Akhouri R; Sotto I; Mulas N; Solano R; Fernández JR; Sanchez S; Shamshad U; Perlyn C; McCafferty-Fernandez J
    Mol Genet Genomic Med; 2019 Sep; 7(9):e922. PubMed ID: 31389673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol.
    Suzuki Y; Someya T; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S
    Ther Drug Monit; 2001 Aug; 23(4):363-8. PubMed ID: 11477317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?
    Dahl ML
    Clin Pharmacokinet; 2002; 41(7):453-70. PubMed ID: 12083975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.
    Martin Ramírez A; Lombardia González C; Soler Maniega T; Gutierrez Liarte Á; Domingo García D; Lanza Suárez M; Bernal Fernández MJ; Rubio JM
    Malar J; 2020 Jul; 19(1):259. PubMed ID: 32680522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.
    Crews KR; Gaedigk A; Dunnenberger HM; Klein TE; Shen DD; Callaghan JT; Kharasch ED; Skaar TC;
    Clin Pharmacol Ther; 2012 Feb; 91(2):321-6. PubMed ID: 22205192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450 CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways.
    Ding S; Yao D; Deeni YY; Burchell B; Wolf CR; Friedberg T
    Biochem J; 2001 Jun; 356(Pt 2):613-9. PubMed ID: 11368792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant treatment and altered CYP2D6 activity: are pharmacokinetic variations clinically relevant?
    D'Empaire I; Guico-Pabia CJ; Preskorn SH
    J Psychiatr Pract; 2011 Sep; 17(5):330-9. PubMed ID: 21926528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
    Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
    Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accurate determination of the CYP2D6 (*1/*4)xN genotype by quantitative PCR.
    Pondman KM; van Schaik RHN; van der Weide J
    Drug Metab Pers Ther; 2018 Mar; 33(1):33-39. PubMed ID: 29420304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.